BNP Paribas Asset Management
RLAY icon

BNP Paribas Asset Management’s Relay Therapeutics RLAY Stock Holding History

BNP Paribas Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3K Sell
1,782
-667
-27% -$9.68K ﹤0.01% 1914
2026
Q1 		$24.4K Buy
2,449
+680
+38% +$6.08K ﹤0.01% 1970
2025
Q4 		$15K Buy
1,769
+151
+9% +$1.08K ﹤0.01% 2041
2025
Q3 		$8K Hold
1,618
– – ﹤0.01% 1706
2025
Q2 		$6K Buy
+1,618
New +$4.81K ﹤0.01% 1956

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BNP Paribas Asset Management's RLAY Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Relay Therapeutics (RLAY) stake by 27% in Q2 2026, selling an estimated $9.68K and leaving 1,782 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1914.

BNP Paribas Asset Management first reported a position in RLAY in Q2 2025 and has held it in 5 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • BNP Paribas Asset Management held 1,782 shares of Relay Therapeutics worth $33.3K as of Q2 2026.
  • BNP Paribas Asset Management sold 667 Relay Therapeutics shares in Q2 2026, an estimated $9.68K.
  • Relay Therapeutics made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1914 holding.
  • BNP Paribas Asset Management first reported a position in Relay Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.